Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Clinical Chemistry
|
January 23, 2010
Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer
John F Timms, Rainer Cramer, Stephane Camuzeaux, et al.
Biochemical Pharmacology
|
June 7, 2015
The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing
Sandra G Gonzalez Malagon, Anna N Melidoni, Diana Hernandez, et al.
The Lancet. Oncology
|
July 14, 2019
Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study
Nuno R Nené, Daniel Reisel, Andreas Leimbach, et al.
International Journal of Cancer
|
September 11, 2014
Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis
Kate Lawrenson, Paulette Mhawech-Fauceglia, Jenny Worthington, et al.
Cancer Research
|
September 28, 2011
AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D
Laurent Dumartin, Hannah J Whiteman, Mark E Weeks, et al.
Cancer Genomics & Proteomics
|
November 17, 2011
Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaks
John F Timms, Usha Menon, Dmitry Devetyarov, et al.
Journal of Proteomics
|
May 15, 2012
Hemopexin is up-regulated in plasma from type 1 diabetes mellitus patients: Role of glucose-induced ROS
Chia-Ching Chen, Ying-Chieh Lu, Yi-Wen Chen, et al.
Plos Pathogens
|
February 23, 2016
Surfactant Protein-D Is Essential for Immunity to Helminth Infection
Sumaiyya Thawer, Jennifer Auret, Corinna Schnoeller, et al.
Proteomics. Clinical Applications
|
October 8, 2014
Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies
John F Timms, Elif Arslan-Low, Musarat Kabir, et al.
BMC Pregnancy and Childbirth
|
January 25, 2017
EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction
Rebecca Spencer, Gareth Ambler, Jana Brodszki, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Clinical Chemistry
|
January 23, 2010
Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer
John F Timms, Rainer Cramer, Stephane Camuzeaux, et al.
Biochemical Pharmacology
|
June 7, 2015
The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing
Sandra G Gonzalez Malagon, Anna N Melidoni, Diana Hernandez, et al.
The Lancet. Oncology
|
July 14, 2019
Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study
Nuno R Nené, Daniel Reisel, Andreas Leimbach, et al.
International Journal of Cancer
|
September 11, 2014
Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis
Kate Lawrenson, Paulette Mhawech-Fauceglia, Jenny Worthington, et al.
Cancer Research
|
September 28, 2011
AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D
Laurent Dumartin, Hannah J Whiteman, Mark E Weeks, et al.
Cancer Genomics & Proteomics
|
November 17, 2011
Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaks
John F Timms, Usha Menon, Dmitry Devetyarov, et al.
Journal of Proteomics
|
May 15, 2012
Hemopexin is up-regulated in plasma from type 1 diabetes mellitus patients: Role of glucose-induced ROS
Chia-Ching Chen, Ying-Chieh Lu, Yi-Wen Chen, et al.
Plos Pathogens
|
February 23, 2016
Surfactant Protein-D Is Essential for Immunity to Helminth Infection
Sumaiyya Thawer, Jennifer Auret, Corinna Schnoeller, et al.
Proteomics. Clinical Applications
|
October 8, 2014
Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies
John F Timms, Elif Arslan-Low, Musarat Kabir, et al.
BMC Pregnancy and Childbirth
|
January 25, 2017
EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction
Rebecca Spencer, Gareth Ambler, Jana Brodszki, et al.
Page
of 8